Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Diagnostics (Basel, Switzerland)
|
August 5, 2020
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
Julius Wehrle, Ulrike Philipp, Martina Jolic, et al.
Blood
|
February 5, 2014
Tracing the development of acute myeloid leukemia in CBL syndrome
Heiko Becker, Kenichi Yoshida, Nadja Blagitko-Dorfs, et al.
British Journal of Haematology
|
November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)
Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series
Olav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Molecular Oncology
|
October 15, 2021
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer
Silvia Waldeck, Jan Mitschke, Sebastian Wiesemann, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
Ola Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Nature Cancer
|
December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Andrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
May 13, 2024
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
Leo R Brown, Mariana S Sousa, Michael S Yule, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Marianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Diagnostics (Basel, Switzerland)
|
August 5, 2020
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
Julius Wehrle, Ulrike Philipp, Martina Jolic, et al.
Blood
|
February 5, 2014
Tracing the development of acute myeloid leukemia in CBL syndrome
Heiko Becker, Kenichi Yoshida, Nadja Blagitko-Dorfs, et al.
British Journal of Haematology
|
November 1, 2018
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)
Jürgen Krauter, Walter Fiedler, Richard F Schlenk, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series
Olav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Molecular Oncology
|
October 15, 2021
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer
Silvia Waldeck, Jan Mitschke, Sebastian Wiesemann, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
Ola Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Nature Cancer
|
December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
Andrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
May 13, 2024
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
Leo R Brown, Mariana S Sousa, Michael S Yule, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Marianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Page
of 4